JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4115 JNJ-7706621
1 Citation

Target: Cyclin-Dependent Kinases|Aurora Kinases

Summary: Potent CDK/Aurora kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL
A4208 NSC 319726

Target: p53

Summary: Reactivator of mutant p53
A4212 Pomalidomide (CC-4047)

Summary: Immunomodulator,antumor/anti-angiogenic

insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
A4237 Amuvatinib (MP-470, HPK 56)

Summary: Tyrosine kinase inhibitor

≥22.4 mg/mL
A2612 MG-115
1 Citation

Target: Proteasome

Summary: Potent reversible proteasome inhibitor

≥23.08 mg/mL
A4303 GSK3787

Summary: PPARβ/δ antagonist,novel and irreversible

insoluble in H2O; ≥15.8 mg/mL
A4323 Vardenafil HCl Trihydrate

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor, potent and selective

≥13.3 mg/mL
A4341 Apixaban

Summary: Factor Xa inhibitor
A1925 Caspase-3/7 Inhibitor I
2 Citation

Target: Caspases

Summary: Caspase-3/7 inhibitor

insoluble in H2O; ≥16.2 mg/mL
A3239 B-HT 920 dihydrochloride

Summary: D2 receptor agonist

≥7.1 mg/mL